CLINICAL_TRIALS
trial_result
· 2013-07-08
Clinical Trial Update: Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome [Phase 3]
Summary
Alcon Research completed a Phase 3 trial of sodium hyaluronate ophthalmic solution 0.18% for dry eye syndrome; results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Dry Eye Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-07-08